Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers

被引:0
|
作者
Sohan Punia
Brian D. Juran
Ahmad H. Ali
Erik M. Schlicht
Raymond M. Moore
Zhifu Sun
Konstantinos N. Lazaridis
机构
[1] Mayo Clinic,Division of Gastroenterology and Hepatology, College of Medicine
[2] Mayo Clinic,Division of Biomedical Statistics and Informatics
来源
BMC Gastroenterology | / 21卷
关键词
PBC; PSC; CfDNA; Liver; Cholestasis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
    Punia, Sohan
    Juran, Brian D.
    Ali, Ahmad H.
    Schlicht, Erik M.
    Moore, Raymond M.
    Sun, Zhifu
    Lazaridis, Konstantinos N.
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [2] Monitoring liver damage using hepatocyte-specific methylation markers in cell-free circulating DNA
    Lehmann-Werman, Roni
    Magenheim, Judith
    Moss, Joshua
    Neiman, Daniel
    Abraham, Ofri
    Piyanzin, Sheina
    Zemmour, Hai
    Fox, Ilana
    Dor, Talya
    Grompe, Markus
    Landesberg, Giora
    Loza, Bao-Li
    Shaked, Abraham
    Olthoff, Kim
    Glaser, Benjamin
    Shemer, Ruth
    Dor, Yuval
    JCI INSIGHT, 2018, 3 (12):
  • [3] Methylation state of circulating cell-free DNA as a prognostic marker for early to late stage chronic liver disease and acute on chronic liver failure
    Tourna, Aikaterini
    Stamouli, Marilena
    Arefaine, Bethlehem
    Baselli, Guido Alessandro
    Valenti, Luca
    Chokshi, Shilpa
    Youngson, Neil
    Patel, Vishal C.
    JOURNAL OF HEPATOLOGY, 2021, 75 : S333 - S334
  • [4] Circulating Liver-Specific miR-122 as a Novel Potential Biomarker for Diagnosis of Cholestatic Liver Injury
    Huang Shifeng
    Wang Danni
    Chen Pu
    Yang Ping
    Cao Ju
    Zhang Liping
    PLOS ONE, 2013, 8 (09):
  • [5] Circulating liver-specific miR-122 as a novel potential biomarker for diagnosis of cholestatic liver injury
    Feng, Huang S.
    Wang, Dan N.
    Chen, Pu
    Yang, Ping
    Ju, Cao
    Ping, Zhang L.
    HEPATOLOGY, 2013, 58 : 396A - 396A
  • [6] Prognostic significance of DNA methylation markers in tissues and corresponding cell-free circulating DNA in NSCLC
    Balgkouranidou, Loanna
    Triantafyllou, Giota
    Theodoropoulos, Christos
    Tsaroucha, Emily
    Kaklamanis, Loukas
    Lianidou, Evi
    CANCER RESEARCH, 2009, 69
  • [7] Prognostic Value of Plasma Cell-free DNA Methylation Markers in Hepatocellular Carcinoma Following Liver Transplantation
    Lu, X. -X.
    Wu, Q. -C.
    Zhou, L.
    Zheng, S. -S.
    TRANSPLANTATION, 2017, 101 (05) : 135 - 136
  • [8] DNA methylation in circulating cell-free DNA of nasopharyngeal carcinoma
    Xu, Yifei
    Ma, Ning
    Midorikawa, Kaoru
    Hiraku, Yusuke
    Oikawa, Shinji
    Zhang, Zhe
    Huang, Guangwu
    Takeuchi, Kazuhiko
    Murata, Mariko
    CANCER SCIENCE, 2018, 109 : 529 - 529
  • [9] Detection of Glioma and Prognostic Subtypes by Noninvasive Circulating Cell-Free DNA Methylation Markers
    Lee, Ian Yu
    Sabedot, Thais
    Malta, Tathiane
    Snyder, James
    Wells, Michael
    DeCarvalho, Ana
    Mukherjee, Abir
    Chitale, Dhananjay
    Asmaro, Karam P.
    Robin, Adam M.
    Rosenblum, Mark L.
    Mikkelsen, Tom
    Rock, Jack P.
    Poisson, Laila
    Walbert, Tobias
    Kalkanis, Steven N.
    Castro, Anavaleria
    Noushmehr, Houtan
    NEUROSURGERY, 2019, 66 : 133 - 133
  • [10] Methylation of cell-free circulating DNA in the diagnosis of cancer
    Warton, Kristina
    Samimi, Goli
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2015, 2